North America In Vitro Fertilization Market Size & Outlook
The in vitro fertilization market in North America is expected to reach a projected revenue of US$ 8,907.5 million by 2033. A compound annual growth rate of 4.39% is expected of North America in vitro fertilization market from 2026 to 2033.
Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility
Other key industry trends
In terms of revenue, North America region accounted for 21.9% of the global in vitro fertilization market in 2025.
Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 16,818.0 million by 2033.
Growth of the In Vitro Fertilization (IVF) market in North America is being driven by several significant factors, including regulatory reforms, government funding for egg/sperm storage, standardization of procedures through automation, and the introduction of new IVF treatments by industry players.
These factors collectively contribute to the expansion & advancement of the IVF market in the region. Furthermore, due to the relatively higher costs of IVF and ICSI treatments in North America, the region is expected to experience steady growth during the forecast period.
For instance, according to recent data by Fertility IQ, a patient spends around USD 20,000 for a single IVF cycle in the U.S. Hence, the increasing cost of IVF treatments, combined with the growing demand in the U.S., has led to a trend where patients are traveling to other countries for treatment.
North America In Vitro Fertilization Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Fertilization Market Outlook will help companies and investors design strategic landscapes.
Fresh Nondonor was the largest segment with a revenue share of 48.71% in 2025.
Horizon Databook has segmented the North America in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2021 to 2033.
Growth of the In Vitro Fertilization (IVF) market in North America is being driven by several significant factors, including regulatory reforms, government funding for egg/sperm storage, standardization of procedures through automation, and the introduction of new IVF treatments by industry players.
These factors collectively contribute to the expansion & advancement of the IVF market in the region. Furthermore, due to the relatively higher costs of IVF and ICSI treatments in North America, the region is expected to experience steady growth during the forecast period.
For instance, according to recent data by Fertility IQ, a patient spends around USD 20,000 for a single IVF cycle in the U.S. Hence, the increasing cost of IVF treatments, combined with the growing demand in the U.S., has led to a trend where patients are traveling to other countries for treatment.
North America In Vitro Fertilization Market Procedure Type Outlook (Revenue, USD Million , 2021-2033)
Fresh Nondonor
Frozen Nondonor
Fresh Donor
Frozen Donor
North America In Vitro Fertilization Market Providers Outlook (Revenue, USD Million , 2021-2033)
Fertility Clinics
Hospitals and Other Settings
Reasons to subscribe to In Vitro Fertilization Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In Vitro Fertilization Market Outlook databook
Our clientele includes a mix of In Vitro Fertilization Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America In Vitro Fertilization Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America In Vitro Fertilization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America In Vitro Fertilization Market, 2021-2033 (US$M)